054050 — NH NongwooBio Co Balance Sheet
0.000.00%
- KR₩128bn
- KR₩106bn
- KR₩159bn
Annual balance sheet for NH NongwooBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 15,457 | 24,131 | 34,445 | 39,769 | 48,086 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 48,326 | 52,134 | 50,330 | 52,592 | 56,716 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 179,398 | 201,066 | 201,720 | 214,387 | 226,469 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 80,116 | 75,202 | 68,475 | 75,467 | 71,364 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 311,049 | 327,393 | 323,809 | 343,309 | 352,925 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 61,469 | 72,910 | 61,795 | 55,742 | 67,732 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 67,414 | 77,950 | 66,442 | 72,499 | 75,215 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 243,634 | 249,442 | 257,366 | 270,811 | 277,709 |
| Total Liabilities & Shareholders' Equity | 311,049 | 327,393 | 323,809 | 343,309 | 352,925 |
| Total Common Shares Outstanding |